1. Metabolism and disposition of lesinurad, a uric acid reabsorption inhibitor, in humans. (3rd July 2019) Authors: Shah, Vishal; Yang, Chun; Shen, Zancong; Kerr, Bradley M.; Tieu, Kathy; Wilson, David M.; Hall, Jesse; Gillen, Michael; Lee, Caroline A. Journal: Xenobiotica Issue: Volume 49:Number 7(2019:Jul.) Page Start: 811 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and efficacy of verinurad, a selective URAT1 inhibitor, for the treatment of patients with gout and/or asymptomatic hyperuricemia in the United States and Japan: Findings from two phase II trials. Issue 6 (2nd November 2019) Authors: Fitz-Patrick, David; Roberson, Kent; Niwa, Kiyoshi; Fujimura, Takabumi; Mori, Koji; Hall, Jesse; Yan, Xiaohong; Shen, Zancong; Liu, Sha; Ito, Yasushi; Baumgartner, Scott Journal: Modern rheumatology Issue: Volume 29:Issue 6(2019) Page Start: 1042 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label study. Issue 1 (8th February 2018) Authors: Fleischmann, Roy; Winkle, Peter; Miner, Jeffrey N; Yan, Xiaohong; Hicks, Liz; Valdez, Shakti; Hall, Jesse; Liu, Sha; Shen, Zancong; Gillen, Michael; Hernandez-Illas, Martha Journal: RMD open Issue: Volume 4:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with febuxostat in adults with gout: a phase IIa, open-label study. Issue 1 (9th April 2018) Authors: Fleischmann, Roy; Winkle, Peter; Hall, Jesse; Valdez, Shakti; Liu, Sha; Yan, Xiaohong; Hicks, Liz; Lee, Caroline; Miner, Jeffrey N; Gillen, Michael; Hernandez-Illas, Martha Journal: RMD open Issue: Volume 4:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Randomized, Multicenter, Double‐Blind, Placebo‐Controlled Study of a Targeted Release Oral Cyclosporine Formulation in the Treatment of Mild to Moderate Ulcerative Colitis: Influence of Immunosuppressants at Baseline: 713. (October 2019) Authors: Bloom, Stuart; Iqbal, Tariq; Nwokolo, Chuka; Jairath, Vipul; Hall, Jesse; Dzyngel, Bruce; Gardzinski, Peter Journal: American journal of gastroenterology Issue: Volume 114 (2019)ACG Abstracts 1:Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pharmacokinetics, pharmacodynamics, and safety of verinurad with and without allopurinol in healthy Asian, Chinese, and non‐Asian participants. Issue 3 (20th May 2022) Authors: Johansson, Susanne; Han, David; Hunt, Thomas; Björck, Karin; Florica, Delia; Gillen, Michael; Hall, Jesse; Erlandsson, Fredrik Journal: Pharmacology research & perspectives Issue: Volume 10:Issue 3(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P053 TARGETED RELEASE ORAL CYCLOSPORINE FORMULATION AS A POTENTIAL NEW THERAPY FOR ULCERATIVE COLITIS. (7th February 2019) Authors: Colombel, Jean-Frederic; Coulter, Ivan S; Hall, Jesse; Rosa, Monica; McDonald, Bernard; Cullen, Alan Journal: Inflammatory bowel diseases Issue: Volume 25(2019)Supplement 1 Page Start: S26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Evaluation of Winter Wheat Genotypes for Weed Competitiveness and Yield under Organic Production Management. Issue 1 (1st July 2014) Authors: Karki, David; Hall, Jesse; Mueller, Nathan; Sexton, Peter Journal: Crop management Issue: Volume 13:Issue 1(2014) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pharmacokinetics, Pharmacodynamics, and Tolerability of Concomitant Multiple Dose Administration of Verinurad (RDEA3170) and Allopurinol in Adult Male Subjects With Gout. (7th May 2018) Authors: Kankam, Martin; Hall, Jesse; Gillen, Michael; Yang, Xiaojuan; Shen, Zancong; Lee, Caroline; Liu, Sha; Miner, Jeffrey N.; Walker, Susan; Clauson, Vicki; Wilson, David; Nguyen, Mai Journal: Journal of clinical pharmacology Issue: Volume 58:Number 9(2018) Page Start: 1214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Differences in Vital Signs Between Elderly and Nonelderly Patients Prior to Ward Cardiac Arrest. Issue 4 (April 2015) Authors: Churpek, Matthew M.; Yuen, Trevor C.; Winslow, Christopher; Hall, Jesse; Edelson, Dana P. Journal: Critical care medicine Issue: Volume 43:Issue 4(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗